249 related articles for article (PubMed ID: 22575167)
1. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
[TBL] [Abstract][Full Text] [Related]
2. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
3. Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17).
Hung CY; Gonzalez A; Wüthrich M; Klein BS; Cole GT
Infect Immun; 2011 Nov; 79(11):4511-22. PubMed ID: 21859851
[TBL] [Abstract][Full Text] [Related]
4. Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.
Hung CY; Zhang H; Castro-Lopez N; Ostroff GR; Khoshlenar P; Abraham A; Cole GT; Negron A; Forsthuber T; Peng T; Galgiani JN; Ampel NM; Yu JJ
Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30104216
[TBL] [Abstract][Full Text] [Related]
5. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.
Hung CY; Wozniak KL; Cole GT
Methods Mol Biol; 2016; 1403():551-66. PubMed ID: 27076153
[TBL] [Abstract][Full Text] [Related]
6. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
7. Vaccinated C57BL/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10.
Hung CY; Castro-Lopez N; Cole GT
Infect Immun; 2014 Feb; 82(2):903-13. PubMed ID: 24478103
[TBL] [Abstract][Full Text] [Related]
8. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.
Hurtgen BJ; Hung CY; Ostroff GR; Levitz SM; Cole GT
Infect Immun; 2012 Nov; 80(11):3960-74. PubMed ID: 22949556
[TBL] [Abstract][Full Text] [Related]
9. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
[TBL] [Abstract][Full Text] [Related]
10. A novel adjuvant for vaccine development in the aged.
Morgan EL; Thoman ML; Sanderson SD; Phillips JA
Vaccine; 2010 Dec; 28(52):8275-9. PubMed ID: 20965299
[TBL] [Abstract][Full Text] [Related]
11. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
Xue J; Hung CY; Yu JJ; Cole GT
Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
[TBL] [Abstract][Full Text] [Related]
12. CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against
Campuzano A; Zhang H; Ostroff GR; Dos Santos Dias L; Wüthrich M; Klein BS; Yu JJ; Lara HH; Lopez-Ribot JL; Hung CY
J Immunol; 2020 Jun; 204(12):3296-3306. PubMed ID: 32358020
[No Abstract] [Full Text] [Related]
13. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
15. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
Jiang C; Magee DM; Ivey FD; Cox RA
Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
[TBL] [Abstract][Full Text] [Related]
16. Single-step conjugation of bioactive peptides to proteins via a self-contained succinimidyl bis-arylhydrazone.
Phillips JA; Morgan EL; Dong Y; Cole GT; McMahan C; Hung CY; Sanderson SD
Bioconjug Chem; 2009 Oct; 20(10):1950-7. PubMed ID: 19788175
[TBL] [Abstract][Full Text] [Related]
17. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor but not Toll-like receptor 2 is essential for MyD88-dependent Th17 immunity to Coccidioides infection.
Hung CY; Jiménez-Alzate Mdel P; Gonzalez A; Wüthrich M; Klein BS; Cole GT
Infect Immun; 2014 May; 82(5):2106-14. PubMed ID: 24614655
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.
Jiang C; Magee DM; Cox RA
Infect Immun; 1999 Nov; 67(11):5848-53. PubMed ID: 10531239
[TBL] [Abstract][Full Text] [Related]
20. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
